Surveillance of Hepatocellular Cancer Among Hepatitis B and Cirrhosis Patients Using Protein Induced by Vitamin K Absence-II (PIVKA-II): A Cost-Utility Analysis for Hong Kong as an Example of Endemic Regions

Home / Key Publications / Health Economics / Surveillance of Hepatocellular Cancer Among Hepatitis B and Cirrhosis Patients Using Protein Induced by Vitamin K Absence-II (PIVKA-II): A Cost-Utility Analysis for Hong Kong as an Example of Endemic Regions

You May Also Like

Advancing womens health key takeaways from AOGIN 2024 featured image

Key Publications

20 November 2024

Advancing women’s health: key takeaways from AOGIN 2024

Expert Opinions

19 November 2024

AOGIN Releases 2024 Position Statement for Cervical Cancer Screening

Expert Opinions

13 September 2024

Empowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour board meetings and patient care management

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.